Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Continuous daily dosing of sunitinib in patients with metastatic renal cell cancer.

Continuous daily dosing of sunitinib in patients with metastatic renal cell cancer. Onkologie. 2008 Sep; 31(8-9):432-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.